Shareholders approved the merger agreement with Sun Pharma USA and a non-binding advisory vote on executive compensation related to the merger. The meeting confirmed a quorum, followed proper procedures, and final voting results will be filed with the SEC.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.